{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:08:09Z","timestamp":1788566889373,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Oglesby Charitable Trust"},{"name":"Pickering Family Charitable Trust"},{"name":"Leukemia and Lymphoma Society, USA"},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5759\/A20971"],"award-info":[{"award-number":["C5759\/A20971"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41375-024-02511-4","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T15:29:07Z","timestamp":1736954947000},"page":"770-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization"],"prefix":"10.1038","volume":"39","author":[{"given":"Hasse M.","family":"Addinsell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0831-0452","authenticated-orcid":false,"given":"Rachel","family":"Cant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-9261","authenticated-orcid":false,"given":"Nathan J.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-4379","authenticated-orcid":false,"given":"Tim C. P.","family":"Somervaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-1402","authenticated-orcid":false,"given":"Daniel H.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-0979","authenticated-orcid":false,"given":"Kiran","family":"Batta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2511_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia."},{"key":"2511_CR2","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/ajh.27271","volume":"99","author":"MM Patnaik","year":"2024","unstructured":"Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. Am J Hematol. 2024;99:1142\u201365.","journal-title":"Am J Hematol"},{"key":"2511_CR3","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","volume":"121","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C, et al. Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013;121:2186\u201398.","journal-title":"Blood"},{"key":"2511_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ccell.2020.04.015","volume":"37","author":"MT Witkowski","year":"2020","unstructured":"Witkowski MT, Dolgalev I, Evensen NA, Ma C, Chambers T, Roberts KG, et al. Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia. Cancer Cell. 2020;37:867\u201382.e812.","journal-title":"Cancer Cell"},{"key":"2511_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41375-018-0203-0","volume":"33","author":"S Niyongere","year":"2019","unstructured":"Niyongere S, Lucas N, Zhou JM, Sansil S, Pomicter AD, Balasis ME, et al. Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML. Leukemia. 2019;33:205\u201316.","journal-title":"Leukemia"},{"key":"2511_CR6","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/cdd.2011.51","volume":"18","author":"G Shu","year":"2011","unstructured":"Shu G, Tang Y, Zhou Y, Wang C, Song J-G. Zac1 is a histone acetylation-regulated NF-\u03baB suppressor that mediates histone deacetylase inhibitor-induced apoptosis. Cell Death Differ. 2011;18:1825\u201335.","journal-title":"Cell Death Differ"},{"key":"2511_CR7","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1182\/bloodadvances.2019000585","volume":"3","author":"A Franzini","year":"2019","unstructured":"Franzini A, Pomicter AD, Yan D, Khorashad JS, Tantravahi SK, Than H, et al. The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations. Blood Adv. 2019;3:2949\u201361.","journal-title":"Blood Adv"},{"key":"2511_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s42003-022-03057-w","volume":"5","author":"E Pronier","year":"2022","unstructured":"Pronier E, Imanci A, Selimoglu-Buet D, Badaoui B, Itzykson R, Roger T, et al. Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes. Commun Biol. 2022;5:110.","journal-title":"Commun Biol"},{"key":"2511_CR9","doi-asserted-by":"crossref","unstructured":"Zhang P, Amarasinghe HE, Whalley JP, Tay C, Fang H, Migliorini G, et al. Epigenomic analysis reveals a dynamic and context-specific macrophage enhancer landscape associated with innate immune activation and tolerance. Genome Biol. 2022;23:1\u201321.","DOI":"10.1186\/s13059-022-02702-1"},{"key":"2511_CR10","doi-asserted-by":"crossref","unstructured":"Viola A, Munari F, S\u00e1nchez-Rodr\u00edguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol. 2019;10:1\u201316.","DOI":"10.3389\/fimmu.2019.01462"},{"key":"2511_CR11","doi-asserted-by":"publisher","first-page":"17253","DOI":"10.1073\/pnas.1308887110","volume":"110","author":"FY McWhorter","year":"2013","unstructured":"McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci USA. 2013;110:17253\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2511_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imbio.2014.09.022","volume":"220","author":"CE Arnold","year":"2015","unstructured":"Arnold CE, Gordon P, Barker RN, Wilson HM. The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses. Immunobiology 2015;220:10\u20139.","journal-title":"Immunobiology"},{"key":"2511_CR13","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1182\/bloodadvances.2020002415","volume":"4","author":"AA Mangaonkar","year":"2020","unstructured":"Mangaonkar AA, Reichard KK, Binder M, Coltro G, Lasho TL, Carr RM, et al. Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia. Blood Adv. 2020;4:5425\u201330.","journal-title":"Blood Adv"},{"key":"2511_CR14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/eji.1830240630","volume":"24","author":"AG Doyle","year":"1994","unstructured":"Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-\u03b3. Eur J Immunology. 1994;24:1441\u20135.","journal-title":"Eur J Immunology"},{"key":"2511_CR15","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41375-018-0121-1","volume":"32","author":"MM Patnaik","year":"2018","unstructured":"Patnaik MM, Vallapureddy R, Lasho TL, Hoversten KP, Finke CM, Ketterling RP, et al. A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone. Leukemia. 2018;32:1850\u20136.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02511-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:11:35Z","timestamp":1741104695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02511-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2511"],"URL":"https:\/\/doi.org\/10.1038\/s41375-024-02511-4","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"PBMNC samples were obtained from CMML patients treated at The Christie NHS Foundation Trust (Manchester, UK) recruited to the Manchester Cancer Research Centre Tissue Biobank (initiated with the approval of South Manchester Research Ethics Committee). PBMNCs from age-matched Healthy volunteers were used as controls. All patients and controls gave informed consent according to the Declaration of Helsinki. The study was approved by the UK Health Research Authority (REC: 19\/LO\/0564).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}